Bioabsorbable Therapeutics
Menlo Park
About Bioabsorbable Therapeutics
Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company uses anti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $9.4M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Mar 2009)
- Website: bioabsorbabletx.com
- Phone: +1 6506170740
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Medical Device
Canonical: https://fsome.com/organization/bioabsorbable-therapeutics-1016287 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.